MUTANTE INTERLEUKIN-2-POLYPEPTIDE
European patent · EP3075745 · Deleted
Register entry
- Publication number
- EP3075745
- Application number
- EP16164244
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 7, 2012
- Published
- Oct 5, 2016
- Granted
- Sep 5, 2018
- Deleted
- Sep 24, 2024
- Reason
- Annual fee unpaid
- IPC classes
- C07K 14/55 (2006.01)C12N 15/26 (2006.01)A61K 39/395 (2006.01)C07K 16/46 (2006.01)C07K 19/00 (2006.01)C07K 14/54 (2006.01)A61K 38/20 (2006.01)C07K 16/30 (2006.01)C07K 16/40 (2006.01)A61K 39/00 (2006.01)A61K 47/68 (2017.01)
- Priority
- EP 11153964 10.02.2011EP 11164237 29.04.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 24, 2024
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 24.09.2024
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 24.09.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Oct 19, 2021
Address changed
- Owner
- Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren
Published in Swissreg on 19.10.2021
- Sep 5, 2018
Granted
Published in Swissreg on 05.09.2018
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.